Ken Kurihara

816 total citations
27 papers, 685 citations indexed

About

Ken Kurihara is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Ken Kurihara has authored 27 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Rheumatology. Recurrent topics in Ken Kurihara's work include Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Ken Kurihara is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Ken Kurihara collaborates with scholars based in Japan, United States and Bulgaria. Ken Kurihara's co-authors include Andrew J. Wardlaw, A B Kay, Adele Hartnell, Garry M. Walsh, Colin J. Sanderson, Oliver Cromwell, A. B. Kay, Roma Sehmi, A KAY and Takashi Ashikaga and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ken Kurihara

25 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Kurihara Japan 9 447 220 197 161 151 27 685
Shinichi Kawabori Japan 16 285 0.6× 185 0.8× 216 1.1× 144 0.9× 141 0.9× 48 568
Jun Atsuta Japan 13 419 0.9× 209 0.9× 182 0.9× 69 0.4× 234 1.5× 21 712
Alfred D. Doyle United States 16 359 0.8× 417 1.9× 138 0.7× 391 2.4× 131 0.9× 35 986
Kristin Chichester United States 19 564 1.3× 623 2.8× 547 2.8× 142 0.9× 105 0.7× 36 1.2k
Takahide Teramoto Japan 15 142 0.3× 186 0.8× 69 0.4× 84 0.5× 74 0.5× 45 570
Ichiro Tojima Japan 14 366 0.8× 227 1.0× 246 1.2× 179 1.1× 86 0.6× 39 691
Erin Gordon United States 13 256 0.6× 197 0.9× 70 0.4× 134 0.8× 164 1.1× 19 509
Lars Lunding Germany 12 251 0.6× 324 1.5× 67 0.3× 56 0.3× 150 1.0× 27 704
Annette Leimgruber Switzerland 13 200 0.4× 113 0.5× 270 1.4× 59 0.4× 34 0.2× 47 529
Tatjana Pecaric-Petkovic Switzerland 6 262 0.6× 450 2.0× 366 1.9× 227 1.4× 26 0.2× 9 866

Countries citing papers authored by Ken Kurihara

Since Specialization
Citations

This map shows the geographic impact of Ken Kurihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kurihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kurihara more than expected).

Fields of papers citing papers by Ken Kurihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Kurihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kurihara. The network helps show where Ken Kurihara may publish in the future.

Co-authorship network of co-authors of Ken Kurihara

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Kurihara. A scholar is included among the top collaborators of Ken Kurihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Kurihara. Ken Kurihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurihara, Ken, et al.. (2022). Five-Year Impacts of Antithrombotic Therapy Based on 10-Year Clinical Outcomes of Cypher™ Stent Implantation. Cardiology and Therapy. 11(3). 433–444. 1 indexed citations
2.
Ashikaga, Takashi, Katsuyuki Hoshina, Taro Sasaoka, et al.. (2021). β-Blockers Reduced the Target Lesion Revascularization After Percutaneous Coronary Intervention Using an Everolimus-eluting Stent. In Vivo. 36(1). 416–423. 4 indexed citations
3.
Ono, Yuichi, Kentaro Goto, Ken Kurihara, et al.. (2021). Fragmented QRS on far‐field intracardiac electrograms as a predictor of arrhythmic events. Journal of Arrhythmia. 37(5). 1156–1161. 1 indexed citations
4.
Goto, Kentaro, Yuichi Ono, Ken Kurihara, et al.. (2021). Incidence of outflow tract ventricular tachycardia long after surgical aortic valve replacement. Journal of Arrhythmia. 37(2). 418–425. 2 indexed citations
6.
Ono, Yuichi, Susumu Tao, Kentaro Goto, et al.. (2019). Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 58(1). 35–41. 6 indexed citations
8.
Ueshima, Daisuke, Shunji Yoshikawa, Taro Sasaoka, et al.. (2018). Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry. Heart and Vessels. 34(2). 218–226. 5 indexed citations
9.
Ueshima, Daisuke, Shunji Yoshikawa, Taro Sasaoka, et al.. (2018). The Hypercholesterolemia Paradox in Percutaneous Coronary Intervention: An Analysis of a Multicenter PCI Registry. Internal Medicine. 58(3). 345–353. 6 indexed citations
10.
Kurihara, Ken, et al.. (2017). Incidence and predictors of early and late target lesion revascularization after everolimus‐eluting stent implantation in unselected patients in japan. Catheterization and Cardiovascular Interventions. 90(1). 78–86. 8 indexed citations
11.
Ueshima, Daisuke, Takashi Ashikaga, Shunji Yoshikawa, et al.. (2016). Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry. Journal of Cardiology. 69(6). 815–822. 5 indexed citations
12.
Ashikaga, Takashi, et al.. (2015). Comparison of outcomes after everolimus-eluting stent implantation in diabetic versus non-diabetic patients in the Tokyo-MD PCI study. Journal of Cardiology. 67(3). 241–247. 17 indexed citations
13.
Ashikaga, Takashi, Kaoru Sakurai, Yasuhiro Satoh, et al.. (2015). Mother-child technique using a novel 4 Fr inner catheter. EuroIntervention. 10(12). 1432–1439. 3 indexed citations
14.
Ashikaga, Takashi, Shunji Yoshikawa, Ken Kurihara, & Mitsuaki Isobe. (2014). Efficacy of mother-child-grandchild technique: 4 F and 5 F inner catheters through mother guide catheter. Cardiovascular revascularization medicine. 15(4). 244–247. 3 indexed citations
15.
Suzuki, Kou, Kenichiro Otomo, Mitsuaki Isobe, et al.. (2011). A case of myotonic dystrophy who developed QT prolongation and torsade de pointes. 43(2). 1 indexed citations
17.
Nakamura, Makoto, et al.. (1994). Taste Receptor Proteins Directly Extracted by Liposome from Intact Epithelium of Bullfrog Tongue. Biochemical and Biophysical Research Communications. 201(1). 415–422. 12 indexed citations
18.
Walsh, Garry M., Adele Hartnell, Andrew J. Wardlaw, et al.. (1990). IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.. PubMed. 71(2). 258–65. 280 indexed citations
20.
Ab, Kay, Redwan Moqbel, Garry M. Walsh, et al.. (1989). The activated eosinophil in allergy and asthma.. PubMed. 297. 183–96; discussion 196. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026